Relmada Therapeutics, Inc. RLMD
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Andrea Tan | Goldman Sachs | 2.95 $ | 2 $ | -0.95 % | 05/06/2024 |
| Andrew Tsai | Jefferies | 6.475 $ | 8 $ | 1.53 % | 13/10/2022 |
| Jay Olson | Oppenheimer | 6.7483 $ | 7 $ | 0.25 % | 13/10/2022 |